Lithium mupirocin,
73346-79-9,
Pseudomonic acid A lithium salt,
Li-MUP,
9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt,
Lithium mupirocin solution,
Lithium mupirocin Supplement,
SCHEMBL1537257,
DTXSID50746663,
AKOS027276158,
Lithium mupirocin, >=95.0% (HPLC),
Lithium mupirocin Supplement, for microbiology,
Mupirocin lithium, British Pharmacopoeia (BP) Reference Standard,
Mupirocin lithium, European Pharmacopoeia (EP) Reference Standard,
Mupirocin lithium, United States Pharmacopeia (USP) Reference Standard,
Lithium 9-({(2E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-({(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl)oxan-2-yl]-3-methylbut-2-enoyl}oxy)nonanoate (non-preferred name),
mupirocin lithium,
Mupirocin,
CS-O-01913,
12650-69-0,